1. Kang, Sujin, Kim, Jaekyung, Park, Areum, Lee, Sungwook, Park, Boyoun. 2023. TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity. In Nature communications, 14, 700. doi:10.1038/s41467-023-36424-0. https://pubmed.ncbi.nlm.nih.gov/36755029/
2. Zhao, Chunyuan, Jia, Mutian, Song, Hui, Zhao, Wei, Cao, Xuetao. . The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I. In Cell reports, 21, 1613-1623. doi:10.1016/j.celrep.2017.10.020. https://pubmed.ncbi.nlm.nih.gov/29117565/
3. Hu, Fangyu, Zhao, Lingling, Wang, Junyu, Huang, Chuanshu, Huang, Haishan. 2024. TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-Myc/p21 axis. In Biochimica et biophysica acta. Molecular cell research, 1871, 119855. doi:10.1016/j.bbamcr.2024.119855. https://pubmed.ncbi.nlm.nih.gov/39357549/
4. Li, ChunYu, Ou, RuWei, Hou, YanBing, Wu, Ying, Shang, HuiFang. 2021. Genetic analysis of TRIM family genes for early-onset Parkinson's disease in Chinese population. In Parkinsonism & related disorders, 90, 105-113. doi:10.1016/j.parkreldis.2021.08.005. https://pubmed.ncbi.nlm.nih.gov/34419804/